Target intelligence / Profile preview

R3HDM2 divergent transcript (R3HDM2-DT)

Target
R3HDM2-DT
Molecular classification
Other (long non-coding RNA)
01

Overview

R3HDM2 divergent transcript (R3HDM2-DT) is a long non-coding RNA (lncRNA) transcribed divergently from the protein-coding R3H domain containing 2 (R3HDM2) locus on chromosome 12q13.3. R3HDM2-DT does not encode a protein but is instead an RNA gene that may play a role in the regulation of its neighboring gene, R3HDM2, or in other regulatory processes. There is currently no evidence that R3HDM2-DT serves as a direct therapeutic target (receptor, enzyme, transporter, etc.), nor is there validated information on its specific biological functions, involvement in diseases, drug interactions, or use as a biomarker. Its primary characterization is being a divergent, non-coding RNA transcript that is likely involved in *cis* or *trans* gene regulation, as is common for many lncRNAs[2][3].

Other names
R3HDM2-DTR3HDM2 Divergent Transcript
02

Biological functions

Unknownlikely regulatory at the RNA level (potential involvement in gene expression or RNA processing)
03

Disease associations

Other (no established direct disease association)

Beyond the preview

Go deeper on R3HDM2 divergent transcript (R3HDM2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on R3HDM2 divergent transcript (R3HDM2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call